| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-08 |